Search - tctmd.com

Displaying 21 - 40 of 48

Sort: Relevancy | Date

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

Presentation TVT 2021

A Novel Embolic Protection System (Filterlex)

Presenter: Haim Danenberg

July 22, 2021

Presentation TVT 2021

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Presenter: George Dangas

July 21, 2021

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TVT 2021

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Presenter: Amar Krishnaswamy

July 21, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Presentation TVT 2019

Status Updates on the Next Generation of Cerebral Protection Devices

Presenter: Giora Weisz

June 13, 2019

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

Presentation TVT 2017

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem

June 15, 2017

Advertisement

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

A Novel Embolic Protection System (Filterlex)

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Status Updates on the Next Generation of Cerebral Protection Devices

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Device Design Features and Findings From EU Clinical Trials

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content